NORTHROP GRUMMAN CORP

Northrop Grumman insider sales on Feb 2 show routine 10b5‑1 portfolio moves, not a downturn, but investors should watch short‑term liquidity and defense‑budget risk.

Northrop Grumman insider filings reveal steady executive holdings amid a defense‑budget‑boosted rally, highlighting long‑term growth while cautioning on a valuation premium.

Northrop Grumman CEO Kathy Warden sells 13,000 shares under Rule 10b5‑1 plan—insider selling hints at planned liquidity, not earnings concerns.